User profiles for Francesca Ingegnoli

Francesca Ingegnoli

Università degli Studi di Milano
Verified email at unimi.it
Cited by 7497

COVID-19 infection and rheumatoid arthritis: Faraway, so close!

EG Favalli, F Ingegnoli, O De Lucia, G Cincinelli… - Autoimmunity …, 2020 - Elsevier
The outbreak of the new coronavirus infections COVID-19 in December 2019 in China has
quickly become a global health emergency. Given the lack of specific anti-viral therapies, the …

Mapping and predicting mortality from systemic sclerosis

…, CM Montecucco, D Opris, F Ingegnoli… - Annals of the …, 2017 - ard.bmj.com
Objectives To determine the causes of death and risk factors in systemic sclerosis (SSc).
Methods Between 2000 and 2011, we examined the death certificates of all French patients …

[HTML][HTML] Rheumatoid factors: clinical applications

F Ingegnoli, R Castelli, R Gualtierotti - Disease markers, 2013 - hindawi.com
Rheumatoid factors are antibodies directed against the Fc region of immunoglobulin G. First
detected in patients with rheumatoid arthritis 70 years ago, they can also be found in …

[HTML][HTML] Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis

V Smith, AL Herrick, F Ingegnoli, N Damjanov… - Autoimmunity …, 2020 - Elsevier
Capillaroscopy is a non-invasive and safe tool which allows the evaluation of the morphology
of the microcirculation. Since its recent incorporation in the 2013 American College of …

Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus

N Ronda, E Favari, MO Borghi, F Ingegnoli… - Annals of the …, 2014 - ard.bmj.com
Objectives The marked cardiovascular risk in autoimmune diseases is only partly explained.
The capacity of high-density lipoproteins (HDL) to promote cell cholesterol efflux is a …

Incidence of COVID‐19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?

EG Favalli, S Monti, F Ingegnoli… - Arthritis & …, 2020 - Wiley Online Library
Objective To describe the incidence and severity of coronavirus disease 2019 (COVID‐19)
in patients with rheumatic diseases treated with targeted synthetic or biologic disease‐…

Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum …

F Ingegnoli, P Boracchi, R Gualtierotti… - … : Official Journal of …, 2008 - Wiley Online Library
Objective To construct a prognostic index based on nailfold capillaroscopic examinations that
is capable of predicting the 5‐year transition from isolated Raynaud's phenomenon (RP) to …

What is the true incidence of COVID-19 in patients with rheumatic diseases?

EG Favalli, F Ingegnoli, R Cimaz… - Annals of the rheumatic …, 2021 - ard.bmj.com
After its emergence in December 2019 in Wuhan, China, the COVID-19 outbreak has now
one of its main epicentres in Lombardy (Italy), with more than 50 000 confirmed cases and …

Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis

…, LM Moronetti, F Ingegnoli… - … : Official Journal of …, 2004 - Wiley Online Library
Objective Circulating endothelial cells (CECs) have been described in different conditions
involving vascular injury. Vascular abnormalities play a key role in the pathogenesis of …

Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database

F Ingegnoli, I Ardoino, P Boracchi, M Cutolo, P Airò… - Microvascular …, 2013 - Elsevier
Objective The aims of this study were to obtain cross-sectional data on capillaroscopy in an
international multi-center cohort of Systemic Sclerosis (SSc) and to investigate the frequency …